γ-Aminobutyric acid transporters as relevant biological target: Their function, structure, inhibitors and role in the therapy of different diseases

被引:42
作者
Latka, Kamil [1 ]
Jonczyk, Jakub [1 ]
Bajda, Marek [1 ]
机构
[1] Jagiellonian Univ, Fac Pharm, Med Coll, Dept Physicochem Drug Anal, Med 9, PL-30688 Krakow, Poland
关键词
GABA transporters; Function; Structure; Inhibitors; Therapy; GABA UPTAKE INHIBITORS; PLASMA-MEMBRANE TRANSPORTER; SLOW-WAVE SLEEP; SUBTYPE-SELECTIVE INHIBITOR; TRANSMEMBRANE DOMAIN-I; HUMAN CEREBRAL-CORTEX; X-RAY STRUCTURES; BETAINE/GABA TRANSPORTER; NIPECOTIC ACID; 2-SUBSTITUTED; 4-HYDROXYBUTANAMIDES;
D O I
10.1016/j.ijbiomac.2020.04.126
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
gamma-Aminobutyric acid (GABA) is a major inhibitory neurotransmitter in the nervous system. It plays a crucial role in many physiological processes. Upon release from the presynaptic element, it is removed from the synaptic cleft by reuptake due to the action of GABA transporters (GATs). GATs belong to a large SLC6 protein family whose characteristic feature is sodium-dependent relocation of neurotransmitters through the cell membrane. GABA transporters are characterized in many contexts, but their spatial structure is not fully known. They are divided into four types, which differ in occurrence and role. Herein, the special attention was paid to these transporting proteins. This comprehensive review presents the current knowledge about GABA transporters. Their distribu-tion in the body, physiological functions and possible utilization in the therapy of different diseases were fully discussed. The important structural features were described based on published data, including sequence analy-sis, mutagenesis studies, and comparison with known SLC6 transporters for leucine (LeuT), dopamine (DAT) and serotonin (SERT). Moreover, the most important inhibitors of GABA transporters of various basic scaffolds, di-verse selectivity and potency were presented. (C) 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:750 / 772
页数:23
相关论文
共 262 条
[91]   Benzodiazepines [J].
Howard, Paul ;
Twycross, Robert ;
Shuster, John ;
Mihalyo, Mary ;
Wilcock, Andrew .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 47 (05) :955-964
[92]   Expression of GABA transporter mRNAs in the developing and adult rat optic nerve [J].
Howd, AG ;
Rattray, M ;
Butt, AM .
NEUROSCIENCE LETTERS, 1997, 235 (1-2) :98-100
[93]  
Hussy N, 2000, ADV EXP MED BIOL, V483, P227
[94]   PRODUCTION OF SPECIFIC ANTIBODIES AGAINST GABA-TRANSPORTER SUBTYPES (GAT1, GAT2, GAT3) AND THEIR APPLICATION TO IMMUNOCYTOCHEMISTRY [J].
IKEGAKI, N ;
SAITO, N ;
HASHIMA, M ;
TANAKA, C .
MOLECULAR BRAIN RESEARCH, 1994, 26 (1-2) :47-54
[95]   Postischemic inhibition of GABA reuptake by tiagabine slows neuronal death in the gerbil hippocampus [J].
Inglefield, JR ;
Perry, JM ;
Schwartz, RD .
HIPPOCAMPUS, 1995, 5 (05) :460-468
[96]   Tiagabine antinociception in rodents depends on GABAB receptor activation:: parallel antinociception testing and medial thalamus GABA microdialysis [J].
Ipponi, A ;
Lamberti, C ;
Medica, A ;
Bartolini, A ;
Malmberg-Aiello, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 368 (2-3) :205-211
[97]   Neuroprotective effect of tiagabine in transient forebrain global ischemia: an in vivo microdialysis, behavioral, and histological study [J].
Iqbal, S ;
Baziany, A ;
Gordon, S ;
Wright, S ;
Hussain, M ;
Miyashita, H ;
Shuaib, A ;
Rajput, AH .
BRAIN RESEARCH, 2002, 946 (02) :162-170
[98]   LOCAL AND DIFFUSE SYNAPTIC ACTIONS OF GABA IN THE HIPPOCAMPUS [J].
ISAACSON, JS ;
SOLIS, JM ;
NICOLL, RA .
NEURON, 1993, 10 (02) :165-175
[99]  
Itouji A, 1996, MOL BRAIN RES, V37, P309
[100]   UPTAKE AND METABOLISM OF GAMMA-AMINOBUTYRIC ACID BY NEURONS AND GLIAL CELLS [J].
IVERSEN, LL ;
KELLY, JS .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (09) :933-938